Søgeresultater - Vranckx, Pascal
- Showing 1 - 20 results of 30
- Go to Next Page
-
1
-
2
-
3
-
4
SPOT the DIAGNOSIS af Verbrugge, Frederik H, Morrow, David A, Vranckx, Pascal
Udgivet 2021Text -
5
-
6
-
7
The multiplication of loaves and fishes approach: a critic to double anti-thrombotics or to double number of ischaemic events? af Gargiulo, Giuseppe, Cannon, Christopher P, Gibson, Charles Michael, Lopes, Renato D, Vranckx, Pascal, Valgimigli, Marco
Udgivet 2020Text -
8
Predicting medical usage rate at mass gathering events in Belgium: development and validation of a nonlinear multivariable regression model af Scheers, Hans, Van Remoortel, Hans, Lauwers, Karen, Gillebeert, Johan, Stroobants, Stijn, Vranckx, Pascal, De Buck, Emmy, Vandekerckhove, Philippe
Udgivet 2022Text -
9
Clinical risk predictors in atrial fibrillation patients following successful coronary stenting: ENTRUST-AF PCI sub-analysis af Goette, Andreas, Eckardt, Lars, Valgimigli, Marco, Lewalter, Thorsten, Laeis, Petra, Reimitz, Paul-Egbert, Smolnik, Rüdiger, Zierhut, Wolfgang, Tijssen, Jan G., Vranckx, Pascal
Udgivet 2020Text -
10
Safety and Efficacy of Double Antithrombotic Therapy With Non–Vitamin K Antagonist Oral Anticoagulants in Patients With Atrial Fibrillation Undergoing Percutaneous Coronary Interve... af Capodanno, Davide, Di Maio, Marco, Greco, Antonio, Bhatt, Deepak L., Gibson, C. Michael, Goette, Andreas, Lopes, Renato D., Mehran, Roxana, Vranckx, Pascal, Angiolillo, Dominick J.
Udgivet 2020Text -
11
Safety and efficacy of double vs. triple antithrombotic therapy in patients with atrial fibrillation with or without acute coronary syndrome undergoing percutaneous coronary interv... af Gargiulo, Giuseppe, Cannon, Christopher P, Gibson, Charles Michael, Goette, Andreas, Lopes, Renato D, Oldgren, Jonas, Korjian, Serge, Windecker, Stephan, Esposito, Giovanni, Vranckx, Pascal, Valgimigli, Marco
Udgivet 2020Text -
12
Edoxaban in atrial fibrillation patients with percutaneous coronary intervention by acute or chronic coronary syndrome presentation: a pre-specified analysis of the ENTRUST-AF PCI... af Vranckx, Pascal, Valgimigli, Marco, Eckardt, Lars, Lewalter, Thorsten, Unikas, Ramunas, Marin, Francisco, Schiele, François, Laeis, Petra, Reimitz, Paul-Egbert, Smolnik, Rüdiger, Zierhut, Wolfgang, Tijssen, Jan, Goette, Andreas
Udgivet 2020Text -
13
Aspirin-free antiplatelet regimens after PCI: insights from the GLOBAL LEADERS trial and beyond af Wang, Rutao, Wu, Sijing, Gamal, Amr, Gao, Chao, Hara, Hironori, Kawashima, Hideyuki, Ono, Masafumi, van Geuns, Robert-Jan, Vranckx, Pascal, Windecker, Stephan, Onuma, Yoshinobu, Serruys, Patrick W, Garg, Scot
Udgivet 2021Text -
14
‘Ticagrelor alone vs. dual antiplatelet therapy from 1 month after drug-eluting coronary stenting among patients with STEMI’: a post hoc analysis of the randomized GLOBAL LEADERS t... af Gamal, Amr S, Hara, Hironori, Tomaniak, Mariusz, Lunardi, Mattia, Gao, Chao, Ono, Masafumi, Kawashima, Hideyuki, Jüni, Peter, Vranckx, Pascal, Windecker, Stephan, Hamm, Christian, Steg, Philippe Gabriel, Onuma, Yoshinobu, Serruys, Patrick W
Udgivet 2021Text -
15
STEMI mortality in community hospitals versus PCI-capable hospitals: results from a nationwide STEMI network programme af Claeys, Marc J, Sinnaeve, Peter R, Convens, Carl, Dubois, Philippe, Boland, Jean, Vranckx, Pascal, Gevaert, Sofie, de Meester, Antoine, Coussement, Patrick, De Raedt, Herbert, Beauloye, Christophe, Renard, Marc, Vrints, Christiaan, Evrard, Patrick
Udgivet 2012Text -
16
Cangrelor, Tirofiban, and Chewed or Standard Prasugrel Regimens in Patients With ST-Segment–Elevation Myocardial Infarction: Primary Results of the FABOLUS-FASTER Trial af Gargiulo, Giuseppe, Esposito, Giovanni, Avvedimento, Marisa, Nagler, Michael, Minuz, Pietro, Campo, Gianluca, Gragnano, Felice, Manavifar, Negar, Piccolo, Raffaele, Tebaldi, Matteo, Cirillo, Plinio, Hunziker, Lukas, Vranckx, Pascal, Leonardi, Sergio, Heg, Dik, Windecker, Stephan, Valgimigli, Marco
Udgivet 2020Text -
17
Efficacy and Safety of Ticagrelor Monotherapy by Clinical Presentation: Pre‐Specified Analysis of the GLOBAL LEADERS Trial af Vranckx, Pascal, Valgimigli, Marco, Odutayo, Ayodele, Serruys, Patrick W., Hamm, Christian, Steg, Philippe Gabriel, Heg, Dik, Mc Fadden, Eugene P., Onuma, Yoshinobu, Benit, Edouard, Janssens, Luc, Diletti, Roberto, Ferrario, Maurizio, Huber, Kurt, Räber, Lorenz, Windecker, Stephan, Jüni, Peter
Udgivet 2021Text -
18
Optimal Antithrombotic Regimens for Patients With Atrial Fibrillation Undergoing Percutaneous Coronary Intervention: An Updated Network Meta-analysis af Lopes, Renato D., Hong, Hwanhee, Harskamp, Ralf E., Bhatt, Deepak L., Mehran, Roxana, Cannon, Christopher P., Granger, Christopher B., Verheugt, Freek W. A., Li, Jianghao, ten Berg, Jurriën M., Sarafoff, Nikolaus, Vranckx, Pascal, Goette, Andreas, Gibson, C. Michael, Alexander, John H.
Udgivet 2020Text -
19
Joint EAPCI/ACVC expert consensus document on percutaneous ventricular assist devices af Chieffo, Alaide, Dudek, Dariusz, Hassager, Christian, Combes, Alain, Gramegna, Mario, Halvorsen, Sigrun, Huber, Kurt, Kunadian, Vijay, Maly, Jiri, Møller, Jacob Eifer, Pappalardo, Federico, Tarantini, Giuseppe, Tavazzi, Guido, Thiele, Holger, Vandenbriele, Christophe, van Mieghem, Nicolas, Vranckx, Pascal, Werner, Nikos, Price, Susanna
Udgivet 2021Text -
20
Peri-procedural use of rivaroxaban in elective percutaneous coronary intervention to treat stable coronary artery disease: The X-PLORER trial af Vranckx, Pascal, Leebeek, Frank W. G., Tijssen, Jan G. P., Koolen, Jacques, Stammen, Francis, Herman, Jean-Paul R., de Winter, Robbert J., van t Hof, Arnout W. J., Backx, Bianca, Lindeboom, Wietze, Kim, So-Young, Kirsch, Bodo, van Eickels, Martin, Misselwitz, Frank, Verheugt, Freek W. A.
Udgivet 2015Text